Status:

UNKNOWN

Multi-omics Characterization of Pancreatic Neuroendocrine Tumors and Carcinomas

Lead Sponsor:

University Hospital, Strasbourg, France

Conditions:

Cancer of Pancreas

Eligibility:

All Genders

18+ years

Brief Summary

In this work, the investigators count through the integrated multi-omics analysis to identify different tumor subgroups in pancreatic neuroendocrine tumors and carcinomas regardless of their grade and...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Adult patient (≥18 years old)
  • Subject with histologically confirmed tumor or neuroendocrine carcinoma of the pancreas
  • Subject with tumors or neuroendocrine carcinoma of the pancreas regardless of the stage of the disease
  • Supported at the University Hospitals of Strasbourg between 01/01/2008 and 01/09/2019
  • Near therapeutic blood count available (less than 6 months)
  • Availability of frozen and/or paraffin tumor material
  • Patients who have already given their consent for their biological resources to be kept at the CRB or in the anatomopathology department of the HUS, and subsequently reused, as well as the anonymous data associated with them, for scientific research purposes.
  • Exclusion criteria:
  • Opposition of the patient to participate in the study
  • Diagnosis other than pancreatic neuroendocrine tumor
  • Biological tissue from a patient who does not meet all the inclusion criteria
  • Impossibility of giving informed information to the subject
  • Patient under judicial protection En savoir plus sur ce texte sourceVous devez indiquer le texte source pour obtenir des informations supplémentaires Envoyer des commentaires Panneaux latéraux

Exclusion

    Key Trial Info

    Start Date :

    December 1 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    June 30 2022

    Estimated Enrollment :

    300 Patients enrolled

    Trial Details

    Trial ID

    NCT05234450

    Start Date

    December 1 2021

    End Date

    June 30 2022

    Last Update

    February 10 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Service d'Oncologie - CHU de Strasbourg - France

    Strasbourg, France, 67091

    Multi-omics Characterization of Pancreatic Neuroendocrine Tumors and Carcinomas | DecenTrialz